REGENXBIO down 1% on pricing 2.7M equity offering

|About: REGENXBIO (RGNX)|By:, SA News Editor

REGENXBIO (NASDAQ:RGNX) has priced an underwritten public offering of 2.7M common shares at $65.00 per share for estimated gross proceeds of $175.5M. Closing date is August 14.

Underwriters over-allotment is an additional 405K common shares.

RGNX -1% premarket.

Previously: REGENXBIO announces proposed equity offering (Aug. 9)

Subscribe for full text news in your inbox